Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TITAN-PARADISE Pilot: Sirolimus-eluting Balloon for Vulnerable Coronary Lesions
NCT06928883Not yet recruiting
- Sponsor
- Cardiocentro Ticino
- Start
- Apr 2025
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Cardiocentro Ticino. Primary endpoint: Absolute change in IVUS-NIRS derived lipid core burden index (MaxLCBI4mm) at 6 months. Planned start Apr 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06928883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06928883.